What were Anuh Pharma Ltd's latest quarterly results?
Anuh Pharma Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: 0.0%
- Revenue Growth YoY: +2.0%
- Operating Margin: 10.0%
Anuh Pharma Ltd: Stock Analysis & Fundamentals
Updated this weekAnuh Pharma Ltd (Pharma - API) — fundamental analysis, earnings data, and key metrics. PE: 19.2. ROE: 12.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Anuh Pharma Ltd Key Facts
What's Happening
👔Promoter buying — stake up 1.9% this quarter
Key Numbers
Current Price
₹79
Dividend Yield
1.90%
Market Cap
790 Cr
Valuation
N/AOther Top Pharma - API Stocks Beating Nifty 500
Frequently Asked Questions: Anuh Pharma Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Anuh Pharma Ltd's current PE ratio?
Anuh Pharma Ltd's current PE ratio is 19.2x.
- Current PE: 19.2x
- Market Cap: 790 Cr
- Dividend Yield: 1.90%
What is Anuh Pharma Ltd's price-to-book ratio?
Anuh Pharma Ltd's price-to-book ratio is 2.3x.
- Price-to-Book (P/B): 2.3x
- Book Value per Share: ₹35
- Current Price: ₹79
Is Anuh Pharma Ltd a fundamentally strong company?
Anuh Pharma Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 16.0%
Is Anuh Pharma Ltd debt free?
Anuh Pharma Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹0 Cr
What is Anuh Pharma Ltd's return on equity (ROE) and ROCE?
Anuh Pharma Ltd's return ratios over recent years
- FY2024: ROCE 26.0%
- FY2025: ROCE 17.0%
- FY2026: ROCE 16.0%
Is Anuh Pharma Ltd's cash flow positive?
Anuh Pharma Ltd's operating cash flow is negative (FY2026).
- Cash from Operations (CFO): ₹-3 Cr
- Free Cash Flow (FCF): ₹15 Cr
- CFO/PAT Ratio: -7% (weak cash conversion)
What is Anuh Pharma Ltd's dividend yield?
Anuh Pharma Ltd's current dividend yield is 1.90%.
- Dividend Yield: 1.90%
- Current Price: ₹79
Who holds Anuh Pharma Ltd shares — promoters, FII, DII?
Anuh Pharma Ltd's shareholding pattern (Mar 2026)
- Promoters: 71.8%
- FII (Foreign): 0.1%
- DII (Domestic): 0.0%
- Public: 28.1%
Is promoter holding increasing or decreasing in Anuh Pharma Ltd?
Anuh Pharma Ltd's promoter holding has decreased recently.
- Current Promoter Holding: 71.8% (Mar 2026)
- Previous Quarter: 71.8% (Dec 2025)
- Change: -0.02% (decreasing — worth monitoring)
Is Anuh Pharma Ltd a new momentum entry or an established outperformer?
Anuh Pharma Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Anuh Pharma Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Anuh Pharma Ltd may be worth studying
- Currently showing mixed signals — monitor for clearer trend confirmation
What is the investment thesis for Anuh Pharma Ltd?
Anuh Pharma Ltd investment thesis summary:
What is the future outlook for Anuh Pharma Ltd?
Anuh Pharma Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.